News 24 | After the international debate about it … “AstraZeneca” adjusts the efficacy rate of its vaccine and reduces it to 76%.

Anglo-Swedish company AstraZeneca has revealed new data related to its vaccine against the emerging coronavirus (Covid 19), announcing that it would reduce the effectiveness of the vaccine from 79% to 76%.

The new updates come after the United States Vaccine Regulatory Authority announced concerns that the company had used old data to determine the vaccine’s effectiveness.

Maine Pangalos, executive vice president of biopharmaceutical research and development at AstraZeneca, said in a statement that the baseline analysis is consistent with our previous analysis and confirms that the vaccine is highly effective in adults.

The company said it plans to seek US approval for the emergency use of its drug in the coming weeks, and has submitted the latest data to the Data Safety Monitoring Board. , the independent committee responsible for overseeing the trial.

And more than 12 countries temporarily stopped using the ‘AstraZeneca’ vaccine this month, after reporting the link to a rare blood clot in a number of people.